DocSym
β
Searchsearch
Search
(N01.4) Rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis
More details coming soon
103 436 in individuals diagnosis rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis confirmed
2 185 deaths with diagnosis rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis
2% mortality rate associated with the disease rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis
Diagnosis rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis is diagnosed Women are 35.75% more likely than Men
33 231
Men receive the diagnosis rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis
937 (2.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
70 205
Women receive the diagnosis rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis
1 248 (1.8 %)Died from this diagnosis.
Risk Group for the Disease rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis - Men aged 55-59 and Women aged 25-29
In Men diagnosis is most often set at age 0-89
Less common in men the disease occurs at Age 90-95+Less common in women the disease occurs at Age 5-9, 90-95+
In Women diagnosis is most often set at age 0-5, 10-89
Disease Features rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis
Absence or low individual and public risk
Rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis - what does this mean
Rapidly progressive nephritic syndrome is a type of glomerulonephritis caused by diffuse endocapillary proliferation, which is the abnormal growth of cells in the glomeruli of the kidneys. this growth of cells can lead to inflammation, scarring, and ultimately, kidney failure.
What happens during the disease - rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis
Rapidly progressive nephritic syndrome is caused by diffuse endocapillary proliferative glomerulonephritis, which results from an immune-mediated inflammatory process in the glomeruli of the kidneys. this damage causes leakage of proteins and red blood cells through the glomerular capillary walls, leading to decreased kidney function, proteinuria, and hematuria.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Urine analysis
- Blood tests to measure kidney function
- Imaging tests such as ultrasound, CT scan or MRI
- Kidney biopsy
- Renal function tests
- Serum creatinine level
- Urinalysis
Treatment and Medical Assistance
Main goal of the treatment: To reduce inflammation and slow the progression of the disease.
- Prescribe anti-inflammatory medications
- Prescribe corticosteroids
- Prescribe immunosuppressant medications
- Perform regular blood tests to monitor kidney function
- Perform regular urine tests to monitor kidney function
- Perform imaging tests such as ultrasound or MRI to check kidney size and shape
- Prescribe diuretics to reduce fluid retention
- Provide dietary and lifestyle advice
- Refer to a nephrologist for further assessment and treatment
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Rapidly progressive nephritic syndrome : diffuse endocapillary proliferative glomerulonephritis - Prevention
Rapidly progressive nephritic syndrome is best prevented by maintaining a healthy lifestyle and avoiding activities that can cause damage to the kidneys, such as smoking, excessive alcohol consumption, and exposure to toxins. it is also important to receive regular checkups and screenings for any underlying conditions that could cause this disease.